Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Autor:
PharmD, Susamma M Wilson, Eduardo Bruera, Aline Rozman de Moraes, Zhanni Lu, Sriram Yennurajalingam, John M Najera, David Hui, Joseph Arthur, Tonya Edwards, Kristy Nguyen, Shirley Darlene Ethridge, Michal J Kubiak, Jimin Wu, Suresh K. Reddy, Yu Qian, Elif Erdogan, Saima Rashid, Manju P Joy, Leela Kuriakose, Jimi S Malik
Publikováno v:
JAMA Oncol
IMPORTANCE: One of the main aims of research on nonmedical opioid use (NMOU) is to reduce the frequency of NMOU behaviors through interventions such as universal screening, reduced opioid exposure, and more intense follow-up of patients with elevated
Publikováno v:
JAMA Otolaryngol Head Neck Surg
Importance The opioid epidemic has reignited interest in opioid-sparing strategies in managing pain. However, few studies have focused on opioid use during perioperative care in patients undergoing head and neck surgery with free flap reconstruction.
Publikováno v:
JAMA Oncology. 6:1102
This cohort study examines the association between prescription drug monitoring program mandates with and without a cancer exemption and the percent of oncologists’ patients with any opioid prescription covered by Medicare Part D.
Publikováno v:
JAMA Oncol
This study analyzes the incidence of opioid-associated deaths in cancer survivors vs the general population in the US from 2006 through 2016 using National Center for Health Statistics death certificate data.
Autor:
Zhanni Lu, David Hui, Joseph Arthur, Bernard Lobato Prado, Eduardo Bruera, Tonya Edwards, Kristy Nguyen
Publikováno v:
JAMA Oncol
This cohort study assesses the frequency of abnormal urine drug test findings among patients with cancer pain treated with long-term opioid therapy who underwent random and targeted testing.
Autor:
Michael J. Englesbe, Sunil Agarwal, Jay S. Lee, Chad M. Brummett, Kao-Ping Chua, Jennifer F. Waljee, Hsou Mei Hu, John D. Bryan, Rebecca L. Haffajee
Publikováno v:
JAMA Network Open
Key Points Question What is the association of opioid prescribing duration limits with postoperative opioid prescribing in Massachusetts and Connecticut? Findings This interrupted time series analysis and cross-sectional study of 16 281 opioid-naive
Autor:
Jessica K Roydhouse, Richard Pazdur, Rajeshwari Sridhara, Pallavi S. Mishra-Kalyani, Laurel A. Menapace, Paul G. Kluetz, Julia A. Beaver, Gideon M. Blumenthal, Daniel L. Suzman
Publikováno v:
JAMA Oncol
Importance Regional variation in opioid use may be attenuated when pharmaceutical-sponsored trials include care that is often standardized by protocols. Understanding such variation is important for global trials that sometimes include time to opioid
Autor:
Colleen M. Brensinger, Craig Newcomb, Hannah Wunsch, Mark D. Neuman, Duminda N. Wijeysundera, Karim S. Ladha, Tobias Svensson, Max Bell, Lakisha J. Gaskins, Brian T. Bateman, Gabriella Bröms, Jennifer Bethell, Linn Hallqvist
Publikováno v:
JAMA Network Open. 2:e1910734
Small studies and anecdotal evidence suggest marked differences in the use of opioids after surgery internationally; however, this has not been evaluated systematically across populations receiving similar procedures in different countries.To determi
Autor:
James A. Tulsky, Isaac S. Chua, Charlotta Lindvall, Emanuele Mazzola, Charles A. Coey, Kate Brizzi, Richard E. Leiter
Publikováno v:
JAMA Oncology. 5:734
This study evaluates the patient demographics and clinical characteristics of 14 095 opioid-related hospitalizations from the US National Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP).
Autor:
James M. Dupree, Jay Lee, Jennifer F. Waljee, Michael J. Englesbe, Caitlin Khalsa, Rena Steiger, Joe Habbouche, Chad M. Brummett
Publikováno v:
JAMA Surgery. 153:1111
Importance In 2014, the US Drug Enforcement Administration moved hydrocodone-containing analgesics from schedule III to the more restrictive schedule II to limit prescribing and decrease nonmedical opioid use. The association of this policy change wi